
Thinner RNFL and GCL were associated with lower Full Scale IQ in childhood and at age 45 years, while thinner RNFL in middle age was associated with greater decline in processing speed.

Thinner RNFL and GCL were associated with lower Full Scale IQ in childhood and at age 45 years, while thinner RNFL in middle age was associated with greater decline in processing speed.

Sharp candidly discusses the need for new solution ideas to strike while the iron is hot, during this rebuilding stage of the healthcare system.

A Finnish national study suggests hard-to-reach adults may seek a flu shot if provided direct information on its benefits.

Progressive familial intrahepatic cholestasis is a genetic liver disease that doesn't only affect the children who are diagnosed, but also the caregivers responsible for them.

Post hoc data from GATHER1 show the complement inhibitor's 18-month benefit in regions including the central fovea.

Data show the 5-year cumulative incidence of glaucoma was 46% among children with bilateral aphakia and 25% with unilateral aphakia.

Some indicators of suboptimal response included discontinuation of anti-TNF therapy for patients with ulcerative colitis and IBD-related hospitalization for patients with Crohn’s disease.

Data show atherosclerotic burden was heterogeneous across LDL-C levels and risk is shown to be consistently associated with plaque burden.

Investigator Andrew T. Chan, MD, MPH, discusses his team's recent findings showing a positive link between primary care providers per capita and community vaccination rates.

Data show ≥60% of eligible faricimab patients with DME could extend treatment to every 4 months, while 95% of ranibizumab implants in wetAMD treatment maintained a six-month schedule.

A new study highlights the urgency to implement better access and distribution of naloxone to avert witnessed opioid overdose deaths.

Dr. Yan noted that increased public awareness among patients and health care providers was essential for earlier detection of melanoma.

Experts explain the societal, systemic, and clinical challenges that come with managing skin disease in people of color.

More than half of dermatology practices have separated in recent years, which has influenced how skin of color and other areas of dermatology study are taught across the United States.

The program has returned with a renewed focus for Black and skin of color-dominant residency programs in addition to those with limited access to mentorship resources.

Dr. Shankar speaks to how physician training and patient conversations can evolve in dermatology through progressive antiracism efforts.

Previous studies reported that skin and soft tissue infections were common among persons experiencing homelessness.

Dr. Lipner says that primary investigators and sub-investigators can advocate for the diversification of clinical trial participants.

People with skin of color are often presumed to suffer fewer negative effects from solar radiation, making the importance of photoprotection in this population understudied and underestimated.

The CDC is encouraging public feedback on updated guideline recommendations for opioid prescribers for the first time since 2016.

New US county data suggest more general and family physicians per capita is positively linked to increased rates of full COVID-19 vaccination.

Steffen Schmitz-Valckenberg, MD, explains the close association between disease progression and uncovered risk alleles.

There was no differences in the incidence of all-cause neonatal hospitalization, post neonatal hospitalizations after birth, congenital anomalies, or infant mortality.

Patients with a positive genetic test showed higher mortality rates compared to genotype-negative patients.

New guidelines recommend healthcare providers develop and implement an individualized nutrition care plan for individuals with diabetes with or at risk of a DFU.

Qbtech is hoping to address some gaps in testing and screening for the specific symptoms of ADHD in individuals aged 6-60.

If approved, dupilumab will be the first biologic medicine available in the US to treat uncontrolled moderate-to-severe atopic dermatitis for young children 6 months to 5 years old.

Veeral S. Sheth, MD, MBA, discusses the potential value of complement inhibitors for the at-need patient population.

Dr. Osunkwo details advancements in the field of sickle cell disease, including chronic disease-managing therapies and stem cell transplant and gene therapies.

Investigators detailed personally mediated, institutional, and internalized antiracism practices that could be applicable to medicine.